CSL Announces Closing of Global Collaboration and Licensing Agreement with Arcturus Therapeutics
/PRNewswire/ -- CSL Limited (ASX:CSL; USOTC:CSLLY) today announced that its subsidiary, CSL Seqirus, finalized its global collaboration and license agreement...